The Development of Anti-Amyloid Therapy for Alzheimer’s Disease: From Secretase Modulators to Polymerisation Inhibitors

By Aisen Paul S.  

CNS Drugs, Vol. 19, Iss. 12, 2005-01 ,pp. : 989-996

Adis International

Access to resources Recommend Favorite

By  

Central Nervous System Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Central Nervous System Agents), Vol. 17, Iss. 1, 2017-02 ,pp. : 3-25

Bentham Science Publishers

Access to resources Recommend Favorite

Interacting with γSecretase for Treating Alzheimer's Disease: From Inhibition to Modulation

By  

Current Medicinal Chemistry, Vol. 18, Iss. 35, 2011-12 ,pp. : 5430-5447

Bentham Science Publishers

Access to resources Recommend Favorite

Advances in the identification of γ-secretase inhibitors for the treatment of Alzheimer's disease

By D'Onofrio Grazia   Panza Francesco   Frisardi Vincenza   Solfrizzi Vincenzo   Imbimbo Bruno P   Paroni Giulia   Cascavilla Leandro   Seripa Davide   Pilotto Alberto  

Expert Opinion on Drug Discovery, Vol. 7, Iss. 1, 2012-01 ,pp. : 19-37

Informa Healthcare

Access to resources Recommend Favorite

γ-Secretase Inhibitors for Alzheimer's Disease: Balancing Efficacy and Toxicity

By Barten Donna M.   Meredith Jere E.   Zaczek Robert   Houston John G.   Albright Charles F.  

Drugs in R&D, Vol. 7, Iss. 2, 2006-01 ,pp. : 87-97

Adis International

Access to resources Recommend Favorite